Cargando…
Chemotherapy Synergizes with Radioimmunotherapy Targeting La Autoantigen in Tumors
BACKGROUND: To date, inefficient delivery of therapeutic doses of radionuclides to solid tumors limits the clinical utility of radioimmunotherapy. We aim to test the therapeutic utility of Yttrium-90 ((90)Y)-radio-conjugates of a monoclonal antibody, which we showed previously to bind specifically t...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2645682/ https://www.ncbi.nlm.nih.gov/pubmed/19247485 http://dx.doi.org/10.1371/journal.pone.0004630 |